Videos

What can we help you find?
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss value-based care and whether or not it poses challenge to data standardization in specialty pharmacy during the NASP Annual Meeting in Washington, DC.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how pharmacy schools can better prepare students for Specialty Pharmacy during the NASP Annual Meeting in Washington, DC.
 
Peer Exchange 2
A comprehensive review of opioid-induced constipation diagnosis strategies and foundational treatment guidelines.
Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.
Opioid-Induced Constipation: Pathophysiology & Disease Burden
A panel of experts considers the disease pathology of opioid-induced constipation and the burden it has on patients.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the benefits of attending NASP during the NASP Annual Meeting in Washington, DC.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Jesse C. Dresser, Esq explains the current climate of PBM reform at the NASP Annual Meeting in Washington, DC.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the goals and importance of his company, Stack, during the NASP Annual Meeting in Washington, DC.
Staff at Green Valley Pharmacy
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about how his employees and why their wellbeing matters. 
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how vertical integration might affect biosimilar availability in specialty pharmacy during the NASP Annual Meeting in Washington, DC.